-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Good blood sugar control can slow the progression of cardiovascular disease and chronic kidney disease
.
The American Diabetes Association (ADA) recommends that the HbA1c target for non-pregnant adults is ≤7%
The HbA1c target for non-pregnant adults is ≤7%
Renal replacement therapy in patients with kidney failure from diabetes and HbA1c levels will remain at 7 percent - the biggest benefit in the range of 8%, because higher levels of HbA1c less than 7% or 8% increase in all-cause and cardiovascular disease mortality Risk
Figure The factors that guide the individual's HbA1c control goal
.
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; G1, eGFR≥90mL/min/1.
Figure The factors that guide the individual's HbA1c control goal
Once every six months HbA1c levels measured every three months to once HbA1c levels the risk of hypoglycemia with decreased glomerular filtration rate increased, primarily in that the use of insulin, sulfonylureas, nateglinide, or class of In the crowd
2 Anemia, hemolysis and iron deficiency caused by the shortened lifespan of red blood cells may all lead to a decrease in HbA1c
Diabetes medication regimens require individualized multiple insulin regimens because patients with chronic kidney disease have a lower clearance rate of insulin and other drugs and are at higher risk of hypoglycemia
[ 1 ] Hahr AJ, Molitch ME, Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.
Am J Kidney Dis 2021 Sep 29[ 1 ] Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.
[ 2 ] Expert consensus on the prevention and treatment of diabetic nephropathy (2014 edition) [J].
Chinese Journal of Diabetes, 2014, 6(11): 792-801.
[ 2 ] Expert consensus on the prevention and treatment of diabetic nephropathy (2014 edition) [J].
[ 3 ] Clinical guidelines for the prevention and treatment of diabetic kidney disease in China [J].
Chinese Journal of Diabetes, 2019(01) : 15-28 Leave a message here
